Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
340b Program Billing
Capture Every 340B Dollar. Protect Every 340B Claim.
AI-enabled 340B program billing ensures compliant savings, maximizes benefit capture, and protects covered entities from HRSA audit and manufacturer compliance risk.
340B
Revenue Gap
20–40%
Drug Cost Savings
$0
Duplicate Billing Risk
15–25%
Eligibility Errors
The 340B program: maximum benefit, minimum risk, but only with compliant execution
The 340B Drug Pricing Program requires manufacturers to provide discounted drugs to eligible covered entities such as DSH, CAH, RRC, and Children’s Hospitals, enabling 20–40% drug cost savings. Nationally, hospitals capture over $4B annually, yet most under-realize benefits due to eligibility errors, billing gaps, and contract pharmacy issues. Non-compliance risks include Medicaid duplicate discounts, HRSA audit repayments, and program termination exposure.
Where 340B program value is lost, key challenge areas?
340B compliance failures and benefit under-capture share common root causes across covered entity types. The following represent the most significant sources of preventable revenue loss and compliance exposure in hospital 340B program management.
Patient Eligibility Determination Errors
340B savings apply only to drugs dispensed to eligible patients in qualifying outpatient encounters. Errors in patient eligibility screening, including failure to capture all qualifying encounter types, incorrect site-of-care attribution, and inadequate documentation of eligibility, result in both under-capture of legitimate savings and compliance exposure when ineligible patients are mistakenly included.
Split Billing System Failures
Split billing systems must accurately separate 340B-eligible from non-340B-eligible drug dispensing to prevent both under-capture and duplicate discount violations. System configuration errors, EHR integration failures, formulary updates, and new drug additions frequently create split billing inaccuracies that often go undetected until HRSA audit exposure and compliance risk review escalation.
Medicaid Duplicate Discount Violations
Federal law prohibits covered entities from receiving both 340B pricing and Medicaid rebates on the same drug unit. Non-compliance with the duplicate discount prohibition creates unlimited repayment liability to state Medicaid programs, and is among the most serious compliance risks HRSA auditors examine closely. Compliant split billing systems are the only reliable protection.
GPO Prohibition Violations
DSH hospitals and certain other covered entity types are prohibited from purchasing drugs through group purchasing organization (GPO) arrangements for use in 340B-eligible patient encounters. GPO prohibition compliance requires careful inventory separation and purchasing pathway management, and oversight violations create repayment obligations and program integrity risk exposure.
Contract Pharmacy Compliance Complexity
Most covered entities dispense 340B drugs through contract pharmacy arrangements rather than in-house dispensing. Manufacturer restrictions on contract pharmacy participation, which have expanded significantly, combined with complex eligibility and dispensing record requirements make contract pharmacy compliance one of the highest-risk areas in 340B program management.
HRSA Audit Exposure
HRSA conducts ongoing audits of covered entities and their contract pharmacies. Audit findings, including eligibility determination failures, duplicate discount violations, and inadequate dispensing records, can result in significant repayment demands, corrective action plans, and in serious cases, program termination. Continuous audit-readiness documentation is the only reliable protection.
AnnexmMed 340B program billing services
AnnexMed delivers 340B program management as a continuous compliance and capture optimization function, not a periodic audit. The following services are structured to maximize eligible drug cost savings while maintaining full regulatory compliance across all HRSA, Medicaid, and payer requirements.
340B Patient Eligibility Determination
Comprehensive patient eligibility screening across all outpatient encounter types: qualifying site-of-care identification, patient-level eligibility verification, encounter documentation standards, and eligibility audit trail maintenance, ensuring all qualifying encounters are captured and no ineligible patients are included.
Split Billing System Management
End-to-end split billing system configuration, validation, and ongoing maintenance: formulary management, EHR integration monitoring, new drug addition workflows, and systematic accuracy testing, preventing the split billing failures that create both under-capture and duplicate discount violations
Medicaid Duplicate Prevention
Automated identification and tracking of Medicaid-covered encounters to prevent simultaneous 340B pricing and Medicaid rebate claims on the same drug unit, with state Medicaid program-specific compliance management and continuous duplicate discount monitoring across all payer submissions.
Contract Pharmacy Compliance
Contract pharmacy arrangement oversight: dispensing record accuracy, manufacturer restriction compliance tracking, eligibility documentation at point of dispensing, and contract pharmacy audit support, managing the highest-complexity compliance area in 340B program administration and governance.
HRSA Audit Readiness Program
Continuous HRSA audit readiness documentation: eligibility determination records, split billing accuracy evidence, duplicate discount compliance documentation, GPO prohibition records, and corrective action documentation, structured to withstand HRSA audit scrutiny and minimize repayment exposure.
GPO Prohibition Compliance
Purchasing pathway management to ensure DSH hospitals and other GPO-prohibited covered entity types maintain compliant drug purchasing separation, and strict inventory tracking, purchase order validation, and GPO prohibition documentation maintained on a continuous ongoing basis throughout operations.
Payer Billing Compliance
340B-specific payer billing requirement management: Medicare Part B billing compliance (340B modifier requirements), commercial payer 340B billing restriction monitoring, and reimbursement rate tracking, ensuring billing accuracy across all payer types and preventing claim denials attributable to 340B billing errors.
340B Program Analytics & Reporting
Comprehensive 340B performance reporting via Data & Analytics Platform: benefit capture by site and drug category, eligibility determination accuracy rates, split billing compliance metrics, contract pharmacy performance, and HRSA audit readiness scores, giving pharmacy directors and CFOs visibility into program performance.
How it works, the AnnexMed 340b program management model?
AnnexMed implements 340B program management through a three-phase continuous model that transforms compliance from a periodic audit into an ongoing operational function embedded in your pharmacy and billing workflow.
-
18+
Years of experience -
40+
Specialties served -
99.1%
Client retention
Phase 1: Assess & Configure
Monitor & Audit-Ready
Comprehensive review of current patient eligibility determination processes, split billing system accuracy, contract pharmacy arrangements, GPO prohibition compliance, and HRSA audit documentation establishing a compliance baseline and quantifying current benefit under-capture.
Eligibility & System Gap Analysis
Identification of all qualifying encounter types not currently captured, split billing system configuration errors, contract pharmacy compliance gaps, and documentation deficiencies creating HRSA audit exposure, with financial impact quantification by gap category.
Phase 2: Implement & Optimize
System & Workflow Redesign
Implement all identified corrections: split billing system reconfiguration, eligibility screening workflow updates, contract pharmacy compliance protocols, GPO prohibition purchasing controls, and Medicaid duplicate discount monitoring, with full change documentation and audit trail.
Capture Optimization
Expand 340B benefit capture to all qualifying encounter types and patient populations, including previously missed outpatient sites, eligible provider types, and drug categories, and continuously maximizing program benefit within compliant eligibility boundaries effectively and consistently.
Phase 3: Monitor & Audit-Ready
Continuous Compliance Monitoring
Ongoing automated monitoring of patient eligibility accuracy, split billing performance, contract pharmacy dispensing records, duplicate discount protection, and GPO prohibition compliance, with real-time alerts when compliance thresholds are breached continuously and immediately.
HRSA Audit Readiness Documentation
Continuous maintenance of HRSA audit documentation packages: eligibility records, split billing accuracy evidence, dispensing records, corrective action histories, and compliance program evidence, ensuring covered entities are audit-ready at all times, not just during audit preparation.
Technology platform, 340B program modules
AnnexMed’s proprietary platforms, ImpactRCM.AI and ImpactBI.AI, include dedicated modules built specifically for 340B program compliance, patient eligibility automation, split billing accuracy, and HRSA audit readiness. These tools eliminate the manual bottlenecks that create both under-capture and compliance risk in traditional 340B program management.
340B Patient Eligibility Engine
Automated screening of outpatient encounters against 340B eligibility criteria by site of care, provider type, encounter type, and patient status, identifying missed qualifying encounters and ineligible inclusions while maintaining HRSA audit-ready eligibility trails.
Split Billing Compliance Monitor
Duplicate Discount Protection Engine
Contract Pharmacy Compliance Tracker
340B Program Analytics Dashboard
Executive reporting on 340B performance including benefit capture, eligibility accuracy, split billing compliance, contract pharmacy metrics, GPO compliance status, and HRSA audit readiness indicators providing pharmacy leaders and CFOs complete program visibility.
HRSA Audit Documentation Suite
Key billing & regulatory reference
Effective 340B program management requires command of the regulatory framework governing covered entity eligibility, drug pricing compliance, Medicaid duplicate discount prohibition, and HRSA standards. The following covers 340B compliance and billing requirements.
Regulatory Dimension
Detail
AnnexMed Approach
340B Program Statute
Section 340B of the Public Health Service Act, requires manufacturers to offer covered outpatient drugs at ceiling price to eligible covered entities; program administered by HRSA Office of Pharmacy Affairs
Full statutory compliance framework integrated into all eligibility determination, purchasing, and dispensing workflows
Covered Entity Eligibility
DSH hospitals, Critical Access Hospitals, Rural Referral Centers, Sole Community Hospitals, Children's Hospitals, and federal grantees (FQHCs, Ryan White, etc.), each with specific eligibility maintenance and documentation requirements
Covered entity type-specific compliance protocols maintained for each client; eligibility documentation updated continuously
Duplicate Discount
Federal prohibition on receiving both 340B pricing and Medicaid drug rebates on the same drug unit, violations carry unlimited repayment liability to state Medicaid programs and are a primary HRSA audit focus
Automated duplicate discount protection covers drug transactions; state Medicaid requirements managed separately.
GPO Purchasing Prohibition
DSH hospitals and certain other covered entities prohibited from purchasing 340B-eligible drugs through GPO arrangements, violations require repayment and create program integrity risk; inventory separation and purchasing controls required
GPO prohibition compliance monitored continuously; purchasing pathway validation integrated into drug procurement workflows
Contract Pharmacy Rules
HRSA guidance allows contract pharmacy arrangements with documentation requirements; manufacturer restrictions have expanded since 2020, limiting contract pharmacy participation for many drugs, compliance complexity continues to increase
Manufacturer restriction tracking maintained by drug and pharmacy; requirements met for contract arrangements.
Medicare Part B Billing
340B drugs billed to Medicare Part B under the average sales price (ASP) minus 22.5% reimbursement formula for outpatient departments; modifier requirements distinguish 340B-acquired drugs; non-compliance creates claim adjustment risk
Medicare Part B modifier compliance and reimbursement rate monitoring integrated into billing workflow for all qualifying claims
HRSA Audit Standards
HRSA conducts covered entity and contract pharmacy audits assessing patient eligibility records, split billing accuracy, duplicate discount compliance, GPO prohibition adherence, and records; findings may require repayment or termination.
Continuous HRSA audit readiness documentation maintained; audit finding risk quantified and tracked through dashboards.
Expected financial outcomes
Hospitals that implement AnnexMed’s Case Management and Utilization Management billing support consistently achieve measurable improvements in status accuracy, denial reduction, and length of stay performance across a 12-month engagement cycle.
20–40%
Drug Cost
Savings
$0
Duplicate
Discount Liability
98%+
Eligibility
Accuracy
100%
HRSA Audit
Readiness
15–25%
Revenue
Protection
Annual
Compliance
Maintained
Why AnnexMed for 340B program billing
Most covered entities manage 340B programs with manual audits, eligibility checks, and reactive corrections. AnnexMed embeds continuous eligibility, split billing, and HRSA audit readiness into workflows.
Continuous 340B Compliance, Not a Periodic Audit
Our 340B program management is continuous, not annual. Eligibility screening, split billing monitoring, duplicate discount protection, and contract pharmacy compliance run in real time, preventing compliance drift and benefit under-capture seen in periodic 340B reviews.
AI-Driven Eligibility Determination at Encounter Scale
AI Agents & Intelligent Automation screens every outpatient encounter against 340B eligibility criteria in real time, identifying qualifying encounters missed by manual processes and flagging ineligible encounters before compliance exposure. Hospitals capture 15–25% more qualifying encounters in the first year.
Automated Duplicate Discount Protection
Medicaid duplicate discount compliance is automated and transaction-level, not sampled. Every drug transaction is screened against Medicaid coverage status to prevent simultaneous 340B pricing and rebate claims, with state-specific Medicaid program requirements managed separately for each covered entity.
Contract Pharmacy Oversight
Contract pharmacy compliance including manufacturer restriction tracking, dispensing accuracy, and eligibility verification at point of dispensing is highly complex. AnnexMed manages it as a dedicated service, ensuring ongoing compliance as restrictions expand.
HRSA Audit Readiness
HRSA audit documentation is maintained continuously, not reactively. Covered entities can respond within days with eligibility records, split billing evidence, duplicate discount documentation, and corrective actions organized to HRSA audit requirements.
No Additional Technology Cost
AI Agents & Intelligent Automation and Data & Analytics Platform are included in the AnnexMed engagement, providing eligibility screening, split billing monitoring, duplicate discount protection, and 340B analytics without additional technology investment.
Identify your 340B capture gap in just 2 weeks
Get a complimentary 340B program assessment. We quantify missed eligibility, split billing gaps, contract pharmacy risks, and HRSA audit exposure, and deliver a plan at no cost.
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Pharmacy directors, CFOs, and revenue integrity leaders at DSH hospitals, Critical Access Hospitals, and Children’s Hospitals rely on AnnexMed to maximize 340B program benefit capture and maintain continuous HRSA audit readiness.
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 2,000+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
